Kathryn Bradley, NP
Nurse Practitioner · Colorado Springs, CONPI 1619619376
Payments from drug & device makers
Across 146 payments — averaging $26.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$505
- Sanofi$356
- Biogen$258
- E.r. Squibb & Sons, L.L.C.$258
- AstraZeneca$232
- Nevro Corp.$211
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,854100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $505 |
| Sanofi | 9 | $356 |
| Biogen | 10 | $258 |
| E.r. Squibb & Sons, L.L.C. | 2 | $258 |
| AstraZeneca | 7 | $232 |
| Nevro Corp. | 4 | $211 |
| Pfizer | 15 | $205 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $203 |
| Livanova USA, Inc. | 2 | $180 |
| Neurocrine Biosciences, Inc. | 4 | $143 |
| Lilly USA, LLC | 3 | $140 |
| Neurelis, Inc. | 3 | $126 |
| Novartis | 6 | $105 |
| SK Life Science, Inc. | 4 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| UCB, Inc. | 2 | $75 |
| W. L. Gore & Associates, Inc. | 1 | $72 |
| Amgen | 3 | $53 |
| Impel Pharmaceuticals Inc. | 2 | $44 |
| Acadia Pharmaceuticals Inc | 2 | $41 |
| Argenx US, Inc. | 2 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $37 |
| Merz Pharmaceuticals, LLC | 2 | $34 |
| Lundbeck LLC | 2 | $32 |
| Acorda Therapeutics, Inc | 1 | $30 |
| Genentech USA, Inc. | 1 | $28 |
| GRT US Holding, Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Tanabe Pharma America, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| MDD US Operations, LLC | 1 | $16 |
| Bristol Myers Squibb | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$173
- Senza$134
- AUBAGIO$127
- NURTEC ODT$123
- ZEPOSIA$119
- EMGALITY$112
How this compares
$3,854 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 32 | $974 |
| Levetiracetam | 12 | $397 |
| Nortriptyline Hcl | 12 | $163 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Colorado Springs
- Deborah HinnenColorado Springs$388K
- Lisa KeithColorado Springs$52K
- Brianne WagnerColorado Springs$11K
- Morgan TevlinColorado Springs$9K
- Jill SmothersColorado Springs$8K
- Tracey PutzColorado Springs$8K
- Chris SchabingerColorado Springs$7K
- Bridget CoyneColorado Springs$6K
- Anne ZobecColorado Springs$5K
- Kathryn BlairColorado Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.